Cormorant Asset Management is a fund manager in Boston with $3.39 bn assets under management.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
Former names
Cormorant Asset Management, LLC
SEC CIK
IRS number
462108927
SEC advisor number
801-79513
FINRA CRD number
167820
AUM ?
$4.02 bn
(as of 30 Mar 24)
Accounts
14
(as of 30 Mar 24)
Employees
14
(6 investment advisory or research)
Address
Cormorant Asset Management
200 CLARENDON STREET
52ND FLOOR
BOSTON
MA 02116
200 CLARENDON STREET
52ND FLOOR
BOSTON
MA 02116
Phone
857-702-0388
Brochures
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Cormorant Asset Management, LP | $3.39 bn | |
Cormorant Global Healthcare Master Fund, LP | $1.26 bn | Hedge Fund |
Cormorant Global Healthcare Fund, LP | ||
Cormorant Global Healthcare Offshore Fund, LTD | ||
Cormorant Private Healthcare Fund I, LP | $204.05 mm | Private Equity Fund |
Cormorant Private Healthcare Offshore Fund I LP | ||
Cormorant Private Healthcare Fund II, LP | $822.96 mm | Private Equity Fund |
Cormorant Private Healthcare Offshore Fund II LP | ||
Cormorant Private Healthcare Fund III, LP | $672.07 mm | Private Equity Fund |
Cormorant Private Healthcare Offshore Fund III LP | ||
Cormorant Private Healthcare Fund IV, LP | $416.40 mm | Private Equity Fund |
Cormorant Private Healthcare Offshore Fund IV, LP |
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Bihua Chen
22 Apr 24
SC 13G/A
Immuneering Corp
15 Apr 24
4
Bihua Chen
3 Apr 24
SC 13G
Ventyx Biosciences, Inc.
21 Mar 24
4
Bihua Chen
18 Mar 24
SC 13G/A
Corbus Pharmaceuticals Holdings, Inc.
18 Mar 24
4
Bihua Chen
11 Mar 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
SC 13G
Neurogene Inc.
14 Feb 24
SC 13G/A
Aerovate Therapeutics, Inc.
14 Feb 24